Security key
10806X102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 172,596,886
- Total 13F value
- $4,393,814,683
- Share change
- -2,681,829
- Put/Call ratio
- 23%
- SEC-reported price per share
- $25.46
- Number of holders
- 251
- Value change
- -$68,086,150
- Number of buys
- 140
- Number of sells
- 107
- Shares outstanding
- 193,965,216
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
251
Top holders
10
BBIO full security history
Ownership snapshot
Full 13F holder table
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kohlberg Kravis Roberts &...
Disclosed value leader
Kohlberg Kravis Roberts &...
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $786,774,395
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Kohlberg Kravis Roberts & Co. L.P. has the largest disclosed position value at $786.77M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kohlberg Kravis Roberts & Co. L.P.'s linked filing trail.
Disclosed position value
Top 5
Kohlberg Kravis Roberts & Co. L.P.
$786.77M
VIKING GLOBAL INVESTORS LP
$636.31M
VANGUARD GROUP INC
$356.01M
BlackRock Finance, Inc.
$315.31M
Aisling Capital Management LP
$153.71M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
Company
|
—
denominator unverified
|
$786,774,395
31,060,971 shares
|
— | 30 Jun 2024 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
—
denominator unverified
|
$636,314,702
25,120,991 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$356,006,766
14,054,748 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$315,314,728
12,448,272 shares
|
— | 30 Jun 2024 |
| Aisling Capital Management LP |
13F
Company
|
—
denominator unverified
|
$153,705,606
6,068,125 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$148,285,366
5,854,140 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
251
Shares
172,596,886
Rows available
251
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
249
Q3 2024 holders
251
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|